Literature DB >> 7526707

In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney.

K Y Ahn1, M G Mohaupt, K M Madsen, B C Kone.   

Abstract

We used in situ hybridization with a digoxigenin-labeled cRNA for inducible nitric oxide synthase (iNOS) to characterize the intrarenal distribution of iNOS transcripts in normal and lipopolysaccharide (LPS)-treated rats. In normal rats, the S3 segment of the proximal tubule, the cortical and medullary thick ascending limb, the distal convoluted tubule, and the cortical and inner medullary collecting duct were intensely labeled, whereas the thin limbs of Henle, proximal convoluted tubule, outer medullary collecting duct, and medullary interstitial cells were weakly labeled. LPS-treated rats exhibited a similar labeling pattern, but with increased staining of mesangial cells, medullary interstitial cells, and papillary surface epithelium. The renal vasculature, including the afferent arteriole, was not labeled in either group. No cellular labeling was observed when the sections were hybridized with the sense iNOS probe. These results indicate that iNOS mRNA is tonically and differentially expressed along the normal rat nephron and that LPS induces iNOS gene expression in normally quiescent mesangial cells, medullary interstitial cells, and papillary surface epithelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526707     DOI: 10.1152/ajprenal.1994.267.5.F748

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  26 in total

Review 1.  The nitric oxide pathway in the cardiovascular system.

Authors:  S Llorens; J Jordán; E Nava
Journal:  J Physiol Biochem       Date:  2002-09       Impact factor: 4.158

2.  In vitro model of sepsis-induced renal epithelial reactive nitrogen species generation.

Authors:  Elina Pathak; Philip R Mayeux
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

Review 3.  Nitric oxide synthesis in the adult and developing kidney.

Authors:  Ki-Hwan Han; Ju-Young Jung; Ku-Yong Chung; Hyang Kim; Jin Kim
Journal:  Electrolyte Blood Press       Date:  2006-03

4.  Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia-reperfusion injury in rat kidney.

Authors:  Kazushige Dobashi; Inderjit Singh; John K Orak; Kohtaro Asayama; Avtar K Singh
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

5.  Effects of endotoxin on tone and pressure-responsiveness of preglomerular juxtamedullary vessels.

Authors:  A A van Lambalgen; N Bouriquet; D Casellas
Journal:  Pflugers Arch       Date:  1996-07       Impact factor: 3.657

6.  Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells.

Authors:  D D Nitsch; N Ghilardi; H Mühl; C Nitsch; B Brüne; J Pfeilschifter
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

7.  Expression of nitric oxide synthase isoforms in the mouse kidney: cellular localization and influence by lipopolysaccharide and Toll-like receptor 4.

Authors:  Bo Holmqvist; Christina Falk Olsson; Maj-Lis Svensson; Catharina Svanborg; Johan Forsell; Per Alm
Journal:  J Mol Histol       Date:  2006-05-19       Impact factor: 2.611

8.  Expression and cellular localization of inducible nitric oxide synthase in lipopolysaccharide-treated rat kidneys.

Authors:  Jae-Youn Choi; Sun-Ah Nam; Dong-Chan Jin; Jin Kim; Jung-Ho Cha
Journal:  J Histochem Cytochem       Date:  2012-01-19       Impact factor: 2.479

9.  Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo.

Authors:  F H Guo; H R De Raeve; T W Rice; D J Stuehr; F B Thunnissen; S C Erzurum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  Nitric oxide decreases expression of osmoprotective genes via direct inhibition of TonEBP transcriptional activity.

Authors:  Wolfgang Neuhofer; Maria-Luisa Fraek; Franz-X Beck
Journal:  Pflugers Arch       Date:  2008-06-21       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.